A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome
- 11 April 2016
- journal article
- letter
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 65 (6) , 765-767
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case reportCancer Immunology, Immunotherapy, 2015